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Abstract. Mammography screening for early detection of breast lesions
currently suffers from high amounts of false positive findings, which result
in unnecessary invasive biopsies. Diffusion-weighted MR images (DWI)
can help to reduce many of these false-positive findings prior to biopsy.
Current approaches estimate tissue properties by means of quantitative
parameters taken from generative, biophysical models fit to the q-space
encoded signal under certain assumptions regarding noise and spatial
homogeneity. This process is prone to fitting instability and partial in-
formation loss due to model simplicity. We reveal unexplored potentials
of the signal by integrating all data processing components into a convo-
lutional neural network (CNN) architecture that is designed to propagate
clinical target information down to the raw input images. This approach
enables simultaneous and target-specific optimization of image normal-
ization, signal exploitation, global representation learning and classifica-
tion. Using a multicentric data set of 222 patients, we demonstrate that
our approach significantly improves clinical decision making with respect
to the current state of the art.
Keywords: q-Space Imaging, Diffusion Imaging, Deep Learning, Diffu-
sion Kurtosis Imaging, Lesion Classification, Convolutional Networks
1 Introduction
Breast cancer is the most frequently diagnosed cancer type among women [1].
While it has been shown that X-ray mammography decreases breast cancer-
related mortality, it suffers from high amounts of false positive findings, which
lead to overdiagnosis of clinically insignificant lesions [2]. Additional non-invasive
examination based on DWI was recently proposed as a powerful yet light-weight
addition to the screening process [3]. In DWI, the signal behavior at different
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diffusion gradients is quantitatively characterized by fitting biophysical models
to the signal and inferring apparent tissue properties from them. The state of the
art method in breast cancer DWI is Diffusion Kurtosis Imaging (DKI), where
the apparent diffusion coefficient (ADC) and the apparent kurtosis coefficient
(AKC) are extracted representing Gaussian and non-Gaussian diffusion, respec-
tively [4, 5]. Using DKI, state of the art results for breast lesion classification
have been reported recently [6, 7]. Model-based methods, however, are simplified
approaches to physical processes, making them prone to partial information loss
and dependent on explicit prior physical knowledge resulting in potential fitting
instabilities and limited generalization abilities. These shortcomings have led to
an emergence of a broad spectrum of signal and noise models designed under
different assumptions. Recent studies in brain imaging have shown how deep
learning can circumvent some of the disadvantages related to classical model-
based approaches in diffusion MRI data processing [8–11]. However, the cur-
rently existing learning-based approaches cannot be more knowledgeable than
the classical model-based approach used as ground truth during training. Thus,
the performance of existing model-free approaches is currently sealed, and the
main benefit so far was found in the reduction of requirements on the input data
side, e.g. saving acquisition time.
In this paper we show in a first clinical scenario how model-free diffusion MRI
can be integrated into an end-to-end training, thus directly relating clinical in-
formation to the raw input signal. By backpropagating this information through
an integrative CNN architecture, simultaneous and target-specific optimization
of image normalization, signal exploitation, global representation learning and
classification is achieved. We demonstrate the superiority of our approach for
clinical decision making by performing breast lesion classification on a multicen-
tral data set of 222 patients with suspicious findings in X-ray mammography.
2 Methods
MRI Dataset This study is performed on a combined data set of 222 patients
acquired in two study sites with 1.5 T MR scanners from different vendors.
Images were acquired with the b-values 0, 100, 750 and 1500 s mm−2 and a slice
thickness of 3 mm. The in-plane resolution of one scanner had to be upsampled
by a factor 2 to match the other scanner’s resolution of 1.25 mm. Figure 1 shows
an example set of diffusion-weighted images for one patient. All patients were
diagnosed with a BI-RADS score of 4 or higher in an earlier X-ray mammography.
Following DWI, core-needle biopsy was performed identifying 122 malignant
and 100 benign lesions. Manual segmentation of regions of interest (ROI) on
the lesions was conducted by an expert radiologist without knowledge about the
biopsy results. 23 of the lesions were not visible on the diffusion-weighted images
and predicted as benign.
b=1500b=100 b=750b=0 b=1500
Fig. 1. Set of diffusion-weighted images at different b-values for one patient including
an example segmentation of a malignant lesion on the b = 1500 s mm−2 image.
Diffusion Kurtosis Imaging DKI is the current state of the art for DWI in
breast cancer. In DKI, the ADC and the AKC indicate presence of diffusion
restricting barriers and tissue heterogeneity. The two coefficients are derived for
every voxel in the ROI by fitting its signal intensities S(b) to:
S(b) = S0 exp
(
−b ADC + 1
6
b2ADC2AKC
)
, (1)
where S0 = S(b = 0) and b is the DWI b-value [4]. The global coefficients of
a lesion are determined by averaging the coefficients of all voxels in the lesion [6].
In this study the signal intensity S0 was omitted during the fit due to its insta-
bility. It was instead used as a third free parameter initialized by the measured
value [12]. The resulting coefficients ADC and AKC were required to lie within
0 < ADC < 3.5 µm2 ms−1 and 0 < AKC < 3, i.e. voxels yielding values outside
these intervals were excluded from the averaging to decrease the influence of
fitting instabilities.
End-to-End q-space Deep Learning The recently proposed q-space deep
learning method [8] uses neural networks to imitate model-based approaches like
DKI by training them on model-derived parameters. In contrast to that method,
we aim to replace the model-based approaches by not using any model-related
parameters as training target. Instead we train our approach directly on targeted
clinical decision. By integrating the entire data processing pipeline into a CNN
and training it end-to-end, this valuable information is backpropagated through
the network optimizing all pipeline components on the specific clinical task. This
enables our approach to yield performances beyond model-based methods. The
proposed architecture consists of four modules:
Input and Image Normalization Module. The proposed CNN architecture is de-
veloped to operate directly on the diffusion-weighted images as input, where
each of the four b-value images is assigned to a corresponding input channel of
the network. For the task of lesion classification every image is cropped to a
bounding box around the segmented ROI and voxels outside of the ROI are set
to 0. Image normalization can be essential when working with raw MRI signal
intensities. To facilitate this step, we measure the mean signal intensity of an ad-
ditional ROI placed in a fat area of a breast in each image. The measured value
is arrayed to match the shape of the corresponding lesion ROI and provided to
the CNN as a fat intensity map in an additional input channel.
Signal Exploitation Module. The input is processed by layers of 1x1 convolutions,
which only convolve the signals in each separate voxel across the input channels.
This method is equivalent to applying a multilayer perceptron to each voxel,
like it is done in q-space Deep Learning, i.e it enables the network to exploit
the information contained in the differently weighted signals for a voxel. The
additional input channel for image normalization extends the set of differently
weighted signals in every voxel by the corresponding value of the fat intensity
map, thus transferring normalizing information about the image into all 1x1
convolutions. Three layers of 1x1 convolutions are applied transforming the input
data into 512 feature maps. In analogy to model-based diffusion coefficients, we
term these representations deep diffusion coefficients (DDC), where each of the
maps corresponds to one coefficient.
Global Representation Learning Module. Learning global representations, e.g.
for texture or geometric analysis, requires inter-voxel convolutions. To this end,
the DDC maps are processed by two blocks of three 3x3 convolutional layers,
while downsampling the input sizes between the blocks using 2x2 max pooling.
In principal, this component can be repeated arbitrarily, but is limited in the
case of lesion classification by the small input sizes of the lesion ROIs.
Binary Classification Module. The final convolutional layer containing the learned
global representations in form of feature maps is followed by a global average
pooling layer, which aggregates the representations by transforming each fea-
ture map into a single mean value. Note, that this all convolutional architecture
allows for variable input sizes by avoiding any classical dense layers, which we ex-
ploit by processing ROIs of different shapes through the same network [13]. The
output is a vector with the length of the number of feature maps containing the
global representations. This feature vector is used as input for a softmax layer
transforming the features into class probabilities, which the binary classification
is performed on using a categorical cross entropy loss function. By training the
proposed network architecture in an end-to-end fashion, image normalization,
signal exploitation and global representations are learned simultaneously and
optimized directly for the classification problem.
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Fig. 2. Detailed network architecture for the different experimental setups explored
in this paper. All convolutional layers use ReLU activation functions. The 5 input
channels receive the diffusion-weighted images at four b-values plus the fat intensity
map.
Experimental Setups In order to investigate the potential improvement of
the proposed approach for clinical decision making, a two step evaluation is per-
formed. First, the model-free signal exploitation is assessed by comparing the
classification performances of the DDC and the means of the model-based coef-
ficients ADC and AKC. A mean DDC is generated by applying the global average
pooling directly to the DDC feature maps. In a second step, the end-to-end (E2E)
approach, and the simultaneous optimization of all DWI data processing compo-
nents in particular, is evaluated by benchmarking it against a model-based CNN
method. For this benchmark, the E2E architecture is modified by feeding para-
metric maps of ADC and AKC into the global representation module instead
of the self-learned DDC feature maps. For simplicity, the benchmark method
is referred to as the fit-to-end method (F2E). All experimental setups and the
detailed network architecture are shown in Figure 2.
Training Details Experiments were run using 10-fold cross validation (CV)
with 80% training data, 10% validation data, and 10% test data, where the
validation data was used for hyper parameter search and the corresponding loss
as a stopping criterion. Batches were generated by randomly sampling 25 slices
of each target class. Notably, all slice samples are mutually exclusive w.r.t single
patients to provide strict data separation. The size of the input layer was chosen
according to the size of the largest lesion in the batch, while zero padding the
smaller lesions. Note, that this method results in batches of variable shape, which
is accounted for by the model’s all convolutional architecture. All images were
masked according to the segmented lesion, i.e. voxels outside the ROI were set
to 0. Data augmentation was performed batch-wise by randomly mirroring left-
right, up-down or rotating by 90◦. Dropout was applied to all convolutional layers
with p = 0.5. The learning rate was initialized at lr = 0.0005 and decreased each
epoch by a factor 0.985. The model was trained using categorical cross-entropy
loss over 12 epochs, processing 100 batches per epoch. Inference was done by
processing each slice j of a patient i individually and weighting the obtained
predictions pi,j with the number of voxels vi,j in the slice against the overall
number of voxels in the lesion v in order to obtain the prediction pi for a patient:
pi =
1
v
s∑
j=1
pi,j ∗ vi,j (2)
An ensemble of fifteen classifiers was trained for each fold of the CV and the
resulting pi for one patient were averaged for the final ensemble prediction.
Statistical Evaluation Models were compared by evaluating the accuracy
score on the test set. The decision threshold tc was chosen at sensitivity se ≥
0.96. This relatively high threshold matches the sensitivity of core-needle biopsy
as reported in literature [14], thus ensuring the integrative character of DWI as
a follow-up study of mammography. The resulting specificities at tc, i.e. the per-
centage of removed false positives from the test set, were tested for significance
using the McNemar-Test (significance level α = 0.05). Note, that statistics were
calculated across all CV folds, i.e. test set predictions of each fold were collected
and fused to a final test set containing all patients.
3 Results
Table 1 shows a comparison amongst all methods explored in this paper. On the
studied data set with 100 benign lesions (false positive mammographic findings)
and 122 malignant lesions (true positive mammographic findings), the previ-
ously chosen decision threshold yields a sensitivity of 0.967 for all methods. This
corresponds to correctly identifying 118 out of the 122 true positives. The E2E
approach shows best performances with an accuracy of 0.815±0.026 and a speci-
ficity at tc of 0.630 ± 0.048, correctly identifying 63 of the 100 false-positives.
This significantly (p-value < 0.01) improves the clinical decisions with respect
to the F2E method, which has an accuracy of 0.743 ± 0.029 and a specificity
Table 1. Results on the test data of all methods explored in this paper.
Method AUC Acc. at tc Spec. (Sens.) at tc tc
E2E 0.907± 0.038 0.815± 0.026 0.630± 0.048 (0.967) ≥ 0.418
F2E 0.886± 0.043 0.743± 0.029 0.470± 0.050 (0.967) ≥ 0.34
DDC 0.868± 0.043 0.770± 0.028 0.530± 0.050 (0.967) ≥ 0.29
ADC 0.827± 0.056 0.734± 0.030 0.450± 0.050 (0.967) ≤ 1.83
AKC 0.799± 0.056 0.734± 0.030 0.450± 0.050 (0.967) ≥ 0.845
at tc of 0.470 ± 0.050, correctly identifying 47 of the 100 false-positives. Com-
paring classification performances of the coefficients without additional global
representation learning, the DDC shows the highest accuracy of 0.770 ± 0.028
and the highest specificity at tc of 0.530± 0.050 outperforming the model-based
coefficients, which both have an accuracy of 0.734 ± 0.030 and a specificity at
tc of 0.450 ± 0.050. As an additional threshold-independent analysis, the area
under the receiver operator curve (AUC) was studied. Here, the E2E approach
is also superior with an AUC 0.907± 0.038 compared to 0.886± 0.043 for F2E.
Among the explored coefficients DDC shows the best AUC with 0.868 ± 0.043
compared to 0.827± 0.056 for ADC and 0.799± 0.056 for AKC.
4 Discussion
The results show that our approach significantly improves clinical decision mak-
ing compared to the current state of the art. We first demonstrate, how data-
driven signal exploitation in DWI outperforms the current model-based methods
and show in a second step how this approach can be integrated into and end-
to-end CNN architecture. On our data set, the end-to-end training is able to
prevent an additional 16 out of 100 women from overdiagnosis with respect to
the benchmark method using model-based coefficients as input. This benchmark
is designed in such a way, that credits for improvement of our approach can be
clearly assigned to the data-driven signal exploitation and its integrability to
joint optimization. In contrast to recent data-driven methods like q-space deep
learning, which are trained on model-related parameters, our end-to-end training
is trained directly on the targeted clinical decision. This enables our approach
to optimize all components of the data processing pipeline simultaneously on
a specific task, thus not being limited by model assumptions. A limitation to
our approach is the dependence on manual segmentation of lesions, which can
be addressed in future studies by integrating automated segmentation into the
network architecture. The dependence on specific b-values as network inputs is
a further limitation, which can be tackled by means like domain adaption [15].
Also we increasingly observe efforts towards standardization of DWI protocols.
The multicentric character of the utilized data set hints upon the generalization
and normalization abilities of the method across different input characteristics.
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